Avexa Limited : Mr Handojo (Jet) Soedirdja resigns as a Non-Executive Director
01/31/2012 | 10:48pm
Avexa Limited
ABN 53 108 150 750
576 Swan Street Richmond
Victoria Australia 3121
Telephone 61 3 9208 4300
Facsimile 61 3 9208 4146
Website www.avexa.com.au
Company announcement
Mr Handojo (Jet) Soedirdja resigns as a Non-Executive
Director
Melbourne, Australia. Tuesday 31 January 2012
The board of Avexa Limited [ASX:AVX] today announced that Mr
Handojo (Jet) Soedirdja has resigned as a Non-Executive
Director due to personal time constraints arising from his
other professional commitments.
Mr Iain Kirkwood, Chairman of Avexa Limited, thanked Mr
Soedirdja for his work with the
company since his appointment to the board on July 2010,
especially in his role as Deputy Chairman, and also for his
valuable input into recent strategic investments made by
Avexa.
"Jet has been a valuable part of the Avexa team, and has
contributed strongly in steering Avexa
through some difficult times. I wish him well for the
future," Mr Kirkwood said.
About Avexa Limited
Avexa Limited is a Melbourne-based biotechnology company with
a focus on discovery, development and commercialisation of
small molecules for the treatment of infectious diseases.
Avexa's key projects include apricitabine (ATC) for the
treatment of drug-resistant HIV, an HIV integrase program and
an antibiotic program for antibiotic-resistant bacterial
infections.
|
For more information:
|
|
|
Mr Iain Kirkwood
Chairman
Ph: +61 3 9208 4300
|
Dr Jonathan Coates Avexa Interim CEO Ph: +61 3 9208
4300
|
Richard Allen
Oxygen Financial Public Relations
Ph: + 61 3 9915 6341
|
www.avexa.com.au
